-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before November 6, 2014. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before November 6, 2014.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of importers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR part. 0, subpart. R, App.
In accordance with 21 CFR 1301.34(a), this is notice that on June 23, 2014, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered as an importer of the following basic classes of controlled substances:
Controlled substance Schedule 3-Fluoro-N-methylcathinone (3-FMC) (1233) I Cathinone (1235) I Methcathinone (1237) I 4-Fluoro-N-methylcathinone (4-FMC) (1238) I Pentedrone (a-methylaminovalerophenone (1246) I Mephedrone (4-Methyl-N-methylcathinone) (1248) I 4-Methyl-N-ethylcathinone (4-MEC) (1249) I Naphyrone (1258) I N-Ethylamphetamine (1475) I N,N-Dimethylamphetamine (1480) I Fenethylline (1503) I Gamma Hydroxybutyric Acid (2010) I Methaqualone (2565) I JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) (6250) I SR-18 and RCS-8 (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) (7008) I 5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone (7011) I AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) (7012) I JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) (7019) I ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) (7035) I APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048) I JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) (7081) I SR-19 and RCS-4 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104) I JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) (7118) I JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) (7122) I UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (7144) I JWH-073 (1-Butyl-3-(1-naphthoyl)indole) (7173) I JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole) (7200) I AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) (7201) I JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) (7203) I PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) (7222) I 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3- carboxylate) (7225) I Alpha-ethyltryptamine (7249) I Ibogaine (7260) I CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297) I CP-47497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7298) I Lysergic acid diethylamide (7315) I 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) (7348) I Marihuana (7360) I Tetrahydrocannabinols (7370) I Parahexyl (7374) I Mescaline (7381) I 2-(4-Elthylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2) (7385) I 3,4,5-Trimethoxyamphetamine (7390) I 4-Bromo-2,5-dimethoxyamphetamine (7391) I 4-Bromo-2,5-dimethoxyphenethylamine (7392) I 4-Methyl-2,5-dimethoxyamphetamine (7395) I 2,5-Dimethoxyamphetamine (7396) I JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole (7398) I 3,4-Methylenedioxyamphetamine (7400) I 5-Methoxy-3,4-methylenedioxyamphetamine (7401) I N-Hydroxy-3,4-methylendioxyamphetamine (7402) I 3,4-Methylenedioxy-N-ethylamphetamine (7404) I 3,4-Methylenedioxymethamphetamine (7405) I Start Printed Page 60500 4-Methoxyamphetamine (7411) I 5-Methoxy-N-N-dimethyltryptamine (7431) I Alpha-methyltryptamine (7432) I Bufotenine (7433) I Diethyltryptamine (7434) I Dimethyltryptamine (7435) I Psilocybin (7437) I Psilocyn (7438) I 5-Methoxy-N,N-diisopropyltryptamine (7439) I N-Ethyl-1-phenylcyclohexylamine (7455) I 1-(1-Phenylcyclohexyl)pyrrolidine (7458) I 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I N-Benzylpiperazine (7493) I 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) (7498) I 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) (7508) I 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) (7509) I 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) (7517) I 2-(4-lodo-2,5-dimethoxyphenyl) ethanamine (2C-I) (7518) I 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) (7519) I 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) (7521) I 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) (7524) I 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4) (7532) I MDPV (3,4-Methylenedioxypyrovalerone) (7535) I 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) (7536) I 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) (7537) I 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) (7538) I Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) I Butylone (7541) I Pentylone (7542) I alpha-pyrrolidinopentiophenone (a-PVP) (7545) I alpha-pyrrolidinobutiophenone (a-PBP) (7546) I AM-694 (1-(5-Fluropentyl)-3-(2-iodobenzoyl) indole) (7694) I Desomorphine (9055) I Etorphine (except HCI) (9056) I Codeine methylbromide (9070) I Heroin (9200) I Morphine-N-oxide (9307) I Normorphine (9313) I Pholcodine (9314) I Acetylmethadol (9601) I Allylprodine (9602) I Alphacetylmethadol except levo-alphacetylmethadol (9603) I Alphameprodine (9604) I Alphamethadol (9605) I Betacetylmethadol (9607) I Betameprodine (9608) I Betamethadol (9609) I Betaprodine (9611) I Dextromoramide (9613) I Dipipanone (9622) I Hydroxypethidine (9627) I Noracymethadol (9633) I Norlevorphanol (9634) I Normethadone (9635) I Racemoramide (9645) I Trimeperidine (9646) I 1-Methyl-4-phenyl-4-propionoxypiperidine (9661) I Tilidine (9750) I Para-Fluorofentanyl (9812) I 3-Methylfentanyl (9813) I Alpha-Methylfentanyl (9814) I Acetyl-alpha-methylfentanyl (9815) I Beta-hydroxyfentanyl (9830) I Beta-hydroxy-3-methylfentanyl (9831) I Alpha-methylthiofentanyl (9832) I 3-Methylthiofentanyl (9833) I Thiofentanyl (9835) I Amphetamine (1100) II Methamphetamine (1105) II Lisdexamfetamine (1205) II Methylphenidate (1724) II Amobarbital (2125) II Pentobarbital (2270) II Secobarbital (2315) II Glutethimide (2550) II Nabilone (7379) II 1-Phenylcyclohexylamine (7460) II Phencyclidine (7471) II Phenylacetone (8501) II 1-Piperidinocyclohexanecarbonitrile (8603) II Alphaprodine (9010) II Cocaine (9041) II Codeine (9050) II Dihydrocodeine (9120) II Oxycodone (9143) II Hydromorphone (9150) II Ecgonine (9180) II Ethylmorphine (9190) II Hydrocodone (9193) II Levomethorphan (9210) II Levorphanol (9220) II Meperidine (9230) II Methadone (9250) II Dextropropoxyphene, bulk (non-dosage forms) (9273) II Morphine (9300) II Oripavine (9330) II Thebaine (9333) II Levo-alphacetylmethadol (9648) II Oxymorphone (9652) II Noroxymorphone (9668) II Poppy Straw Concentrate (9670) II Racemethorphan (9732) II Alfentanil (9737) II Remifentanil (9739) II Sufentanil (9740) II Carfentanil (9743) II Tapentadol (9780) II Fentanyl (9801) II The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards and distribution to their research and forensic customers.
In reference to drug codes 7360 and 7370, the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activity for these drug codes are authorized for this registration.
Comments and requests for hearing on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007).
Start SignatureDated: September 25, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-23832 Filed 10-6-14; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 10/07/2014
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2014-23832
- Dates:
- Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before November 6, 2014. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before November 6, 2014.
- Pages:
- 60499-60500 (2 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2014-23832.pdf